-
Understand What I Mean, Not What I Say
Oct 2, 2017, 10:45 AM by Michael CroftFull storyBio-IT World Contributed Commentary | In the field of biobanking, where it is common for biobanks to evolve for different purposes, in disparate locations, and with isolated informatics systems, it’s no surprise that communication within and across biobanks, even within one institution, is challenging and fraught with miscommunications.
-
Security Takes On Malicious DNA (Files)
Sep 29, 2017, 15:20 PM by Michael CroftSecurity Now | Securing biomedical research can mean protecting systems from malicious code in the samples under investigation, University of Washington security researchers say.Full story -
Standardized Interpretation Pipelines Will Be Essential For Genomic Medicine
Sep 29, 2017, 10:50 AM by Michael CroftFull storyBio-IT World Contributed Commentary | Next-generation sequencing continues to offer new hope for scientists and clinicians focused on everything from rare disease to cancer. Still, the clinical application of genomics could use some crucial improvements— perhaps none more urgent than standardized automated tools for genome interpretation.
-
The Zika Virus Grew Deadlier With A Small Mutation Study Suggests
Sep 28, 2017, 15:09 PM by Michael CroftThe New York Times | A single variation in its DNA may have helped equip the virus to attack fetal cells, contributing to a surge of birth defects in Latin America.Full story -
As Consumer DNA Testing Grows, Two States Resist
Sep 28, 2017, 14:46 PM by Michael CroftMIT Technology Review | Maryland and New York still restrict who can order genetic tests and how companies can market them.Full story -
Celgene’s Big Data IQ
Sep 28, 2017, 09:20 AM by Michael CroftFull storyBio-IT World | In recent years, Celgene has been doubling down on its information analytics capabilities, and in January it launched an internal big data platform to more cohesively manage data to drive decision-making from pre-clinical research through commercialization.
-
Genedata Screener Strengthens Collaborative Research at Axxam
Sep 27, 2017, 08:36 AM by Michael CroftBASEL, SWITZERLAND - Sep 27, 2017 - Genedata, a leading provider of advanced software solutions for R&D, today announced that Axxam has extended its licensing of Genedata Screener® as its collaborative research platform for data analysis of high-throughput screening, compound profiling, and safety screening campaignsFull story -
Adam Rutherford to speak at Lab Innovations 2017
Sep 26, 2017, 11:24 AM by Michael Croft, ENGLAND - Sep 26, 2017 - Lab Innovations – the UKs only dedicated showcase for laboratory, analytical and biotech equipment – returns to the NEC, Birmingham, for its sixth consecutive year on the 1st and 2nd of November 2017Full story -
SIRION Biotech and Vibalogics partner to offer complete Adeno-Associated Virus (AAV) services
Sep 26, 2017, 11:17 AM by Michael Croft- Sep 26, 2017 - Munich, Germany - SIRION Biotech GmbH and Vibalogics GmbH, have signed a strategic partnership agreement designed to meet demand from gene therapy companies for a start-to-finish Adeno-Associated Virus (AAV) serviceFull story -
The drug-makers guide to the galaxy
Sep 26, 2017, 10:40 AM by Michael CroftNature News & Comment | How machine learning and big data are helping chemists search the vast chemical universe for better medicines.Full story -
Quanticate reinforces global offering with new Indian office
Sep 26, 2017, 07:32 AM by Michael CroftBANGALORE, INDIA - Sep 26, 2017 - Quanticate, a global data-focused clinical research organisation (CRO), is further expanding its service offering into India with the opening of a new officeFull story -
StemExpress Signs Distribution Agreement with CliniSciences
Sep 25, 2017, 17:31 PM by Michael CroftFOLSOM, CA - Sep 26, 2017 - StemExpress is a premier provider of human blood-derived cell products, including bone marrow, cord blood, peripheral blood, Leukopaks®, Mobilized Leukopaks, and primary cellsFull story -
Deep Genomics Raises $13 Million To Develop Genetic Medicines
Sep 25, 2017, 16:10 PM by Michael CroftFull storyBio-IT World Brief | Deep Genomics received a USD $13 million equity investment led by Khosla Ventures. They are accompanied by early stage investment firm True Ventures. In the next three years, Deep Genomics will use its platform to unlock new classes of anti-sense oligonucleotide therapies that were previously inaccessible, and advance them for clinical evaluation.
-
Congenica, PerkinElmer, Illumina, And More: News From September 2017
Sep 25, 2017, 14:15 PM by Michael CroftFull storyBio-IT World | September featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Congenica, PerkinElmer, Illumina, and more.
-
Jackson Lab Files Federal Complaint, Accusing Chinese University Of Selling Its Mice
Sep 22, 2017, 13:30 PM by Michael CroftFull storyHartford Courant | The Jackson Laboratory is suing to stop Nanjing University, whom it accuses of selling offspring of the genomics center’s mice used for research.
-
BioIVT Expands its Support of the Annual North American ISSX Meeting; Highlights Advances in Drug Metabolism and Toxicology Research
Sep 21, 2017, 12:43 PM by Michael CroftWESTBURY, NY - Sep 21, 2017 - BioIVT, a leading provider of biospecimens and related services, today announced that it is increasing its support of the annual North American International Society for the Study of Xenobiotics (ISSX) MeetingFull story -
Even At $500K, Gene Therapy Could Be A Bargain For Some Diseases
Sep 21, 2017, 08:53 AM by Michael CroftMIT Technology Review | A one-time gene therapy that costs half a million dollars sounds crazy until you add up what it costs to treat some diseases over a lifetime.Full story -
ABL acquisition extends Ardena’s early-phase offering
Sep 21, 2017, 05:38 AM by Michael Croft- Sep 21, 2017 - Early-phase contract development and manufacturing organisation (CDMO), Ardena, has acquired bioanalytical contract laboratory, Analytical Biochemical Laboratory (ABL)Full story -
MDI Biological Laboratory Study Finds Immune System Is Critical to Regeneration
Sep 20, 2017, 15:30 PM by Michael CroftBAR HARBOR, ME, UNITED STATES - Sep 20, 2017 - The answer to regenerative medicines most compelling question -- why some organisms can regenerate major body parts such as hearts and limbs while others, such as humans, cannot -- may lie with the bodys innate immune system, according to a new study of heart regeneration in the axolotl, or Mexican salamander, an organism that takes the prize as natures champion of regenerationFull story -
CRISPR Used To Peer Into Human Embryo's First Days
Sep 20, 2017, 13:38 PM by Michael CroftNature News & Comment | Gene-edited embryos enable researchers to unpick role of a crucial gene, with more studies likely to follow.Full story